期刊
MOLECULAR MEDICINE REPORTS
卷 25, 期 1, 页码 -出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/mmr.2021.12545
关键词
HO-1; promoter polymorphism; (GT)n dinucleotide polymorphism; T(-413)A single nucleotide polymorphism; diseases
资金
- National Natural Science Foundation of China [81902052]
This article reviews the association between the polymorphisms of the heme oxygenase-1 (HO-1) gene and various diseases, providing insights for potential strategies in diagnosis, treatment, and prognosis of these diseases.
Heme oxygenase-1 (HO-1) is an inducible cytoprotective enzyme that degrades heme into free iron, carbon monoxide and biliverdin, which is then rapidly converted into bilirubin. These degradation products serve an important role in the regulation of inflammation, oxidative stress and apoptosis. While the expression level of HO-1 is typically low in most cells, it may be highly expressed when induced by a variety of stimulating factors, a process that contributes to the regulation of cell homeostasis. In the 5 '-non-coding region of the HO-1 gene, there are two polymorphic sites, namely the (GT)n dinucleotide and T(-413)A single nucleotide polymorphism sites, which regulate the transcriptional activity of HO-1. These polymorphisms have been shown to be closely associated with the occurrence and progression of numerous diseases, including cardiovascular, pulmonary, liver and kidney, various types of cancer and viral diseases. The present article reviews the progress that has been made in research on the association between the two types of polymorphisms and these diseases, which is expected to provide novel strategies for the diagnosis, treatment and prognosis of various diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据